Literature DB >> 21910720

High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies.

Elaine M Boyd1, Anthony J Bench, Mars B van 't Veer, Penny Wright, David M Bloxham, George A Follows, Mike A Scott.   

Abstract

The BRAF V600E mutation has recently been described in all cases of hairy cell leukaemia (HCL). We have developed and validated a rapid and sensitive high-resolution melting analysis (HRMA) assay that detects BRAF exon 15 mutations when hairy cells are as low as 5-10% in a sample. All 48 HCL patients were positive for the BRAF V600E mutation, while 114 non-HCL cases were all V600E negative. Interestingly, we detected a novel BRAF D594N mutation in one patient with multiple myeloma. The HRMA assay offers a useful tool to aid the laboratory diagnosis of HCL.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910720     DOI: 10.1111/j.1365-2141.2011.08868.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  24 in total

1.  Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.

Authors:  Liqiang Xi; Evgeny Arons; Winnifred Navarro; Katherine R Calvo; Maryalice Stetler-Stevenson; Mark Raffeld; Robert J Kreitman
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

2.  A quantitative allele-specific PCR test for the BRAF V600E mutation using a single heterozygous control plasmid for quantitation: a model for qPCR testing without standard curves.

Authors:  Philippe Szankasi; N Scott Reading; Cecily P Vaughn; Josef T Prchal; David W Bahler; Todd W Kelley
Journal:  J Mol Diagn       Date:  2013-01-08       Impact factor: 5.568

Review 3.  Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.

Authors:  Arantza Onaindia; L Jeffrey Medeiros; Keyur P Patel
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

4.  Immunohistochemical analysis using a BRAF V600E mutation specific antibody is highly sensitive and specific for the diagnosis of hairy cell leukemia.

Authors:  Xuan J Wang; Annette Kim; Shaoying Li
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay.

Authors:  Shalini Verma; Wesley O Greaves; Farhad Ravandi; Neelima Reddy; Carlos E Bueso-Ramos; Susan O'Brien; Deborah A Thomas; Hagop Kantarjian; L Jeffrey Medeiros; Rajyalakshmi Luthra; Keyur P Patel
Journal:  Am J Clin Pathol       Date:  2012-07       Impact factor: 2.493

6.  Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders.

Authors:  Piers A Blombery; Stephen Q Wong; Chelsee A Hewitt; Alexander Dobrovic; Ellen L Maxwell; Surender Juneja; George Grigoriadis; David A Westerman
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

Review 7.  Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.

Authors:  Frank S Ong; Kingshuk Das; Jay Wang; Hana Vakil; Jane Z Kuo; Wendell-Lamar B Blackwell; Stephen W Lim; Mark O Goodarzi; Kenneth E Bernstein; Jerome I Rotter; Wayne W Grody
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225

Review 8.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

9.  Absence of BRAF exon 15 mutations in multiple myeloma and Waldenström's macroglobulinemia questions its validity as a therapeutic target in plasma cell neoplasias.

Authors:  Eleftheria Hatzimichael; Samuel Murray; Evangelos Briasoulis
Journal:  Am J Blood Res       Date:  2013-05-05

10.  Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.

Authors:  Enrico Tiacci; Gianluca Schiavoni; Maria Paola Martelli; Emanuela Boveri; Roberta Pacini; Alessia Tabarrini; Silvia Zibellini; Alessia Santi; Valentina Pettirossi; Elisabetta Fortini; Stefano Ascani; Luca Arcaini; Giorgio Inghirami; Marco Paulli; Brunangelo Falini
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.